Pseudomonas infections in patients with AIDS and AIDS-related complex. NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Pseudomonas infections in patients with AIDS and AIDS-related complex.

J Intern Med. 1992 Apr;231(4):437-43. Unique Identifier : AIDSLINE MED/92268786
Franzetti F; Cernuschi M; Esposito R; Moroni M; Clinic of Infectious Diseases, University of Milan, Italy.

Abstract: We identified and reviewed retrospectively all the cases of infection by Pseudomonas and related genera in patients with AIDS and AIDS-related complex (ARC) who were hospitalized at our Institution over a 36-month period. We recorded 48 episodes of infection in 34 of 355 patients with AIDS, and in two of 73 patients with ARC: 25 pneumonias (9 community-acquired and 16 of nosocomial origin). 20 urinary tract infections, two soft tissue infections and one sepsis. In 14 of 16 patients with nosocomial pneumonia but in only one of nine patients with community-acquired pneumonia did we find coexisting opportunistic lung diseases. The following micro-organisms were isolated: P. aeruginosa in 41 cases, P. fluorescens in three cases, Xanthomonas maltophilia (P. maltophilia) in two cases, P. putida in one case. Comamonas testosteronis (P. testosteronis) and Comamonas acidovorans (P. acidovorans) in one case. Amikacin and ceftazidime, alone or in combination, appear to be the optimal choice of therapy for severe Pseudomonas infections in HIV-infected patients, although in our study six of 47 isolates were resistant in vitro to amikacin, and nine of 31 isolates were resistant to ceftazidime.
Keywords: Acquired Immunodeficiency Syndrome/*COMPLICATIONS Adult AIDS-Related Complex/*COMPLICATIONS Female Human Italy/EPIDEMIOLOGY Male Microbial Sensitivity Tests Opportunistic Infections/*COMPLICATIONS/DRUG THERAPY/EPIDEMIOLOGY Pneumonia/MICROBIOLOGY Pseudomonas Infections/*COMPLICATIONS/DRUG THERAPY/EPIDEMIOLOGY Retrospective Studies Urinary Tract Infections/MICROBIOLOGY JOURNAL ARTICLEKWDacquiredimmunodeficiencysyndrome/KWDcomplicationsadultaids-relatedcomplex/KWDcomplicationsfemalehumanitaly/epidemiologymalemicrobialsensitivitytestsopportunisticinfections/KWDcomplications/drugtherapy/epidemiologypneumonia/microbiologypseudomonasinfections/KWDcomplications/drugtherapy/epidemiologyretrospectivestudiesurinarytractinfections/microbiologyjournalarticle
920830
M9280276

Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .